Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Medical 3D printing expert Summer Decker, PhD, professor and vice chair for research and innovation, and director of 3D clinical applications, University of South Florida (USF) Morsani College of Medicine and Tampa General Hospital, explains what is involved in creating a 3D printiung program in radiology and how it helps patient care.

Pitching the business case for 3D printing labs in radiology

Medical 3D printing expert Summer Decker, PhD, University of South Florida, explains how her lab has helped improve patient care. 

private equity corporatization business consolidation

Most physicians think private equity is bad for healthcare

Just 10.5% of U.S. physicians said they view private equity ownership in healthcare in a positive light. 

Thumbnail

Daylight saving time boosts malpractice severity, payouts

As most of the U.S. shifts to daylight saving time this week, a new study reveals that malpractice severity and payment decisions are higher in this part of the year than during standard time.

Top patient safety concerns dangers hazards

ECRI out with 2024’s top 10 patient safety hazards

Bringing inexperienced clinicians up to speed on real-world patient care is now the No. 1 safety issue troubling healthcare providers. 

Thumbnail

Elevance closes on Paragon acquisition

While details of financial terms were not disclosed by the companies, a report from Axios pegged the deal at “well north of $1 billion.”

returns on investment in healthcare artificial intelligence

When big returns on AI investment arrive in healthcare, providers will lag behind suppliers in marking the moment: Moody’s

Years will pass before the global economy’s healthcare sector sufficiently leverages AI to build major financial muscle off of it. And even then, industry players are likely to see gains well ahead of hospitals and health systems. 

mark cuban pharmacy benefits managers

Mark Cuban to CEOs: ‘If you’re using a Big 3 pharmacy benefits manager, you are getting ripped off. Period. End of story.’

The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

hospital price transparency

Transparency report called ‘irresponsible,’ ‘reckless’

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.